Eritrea vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
Eritrea
100.0%
in 2024
South-East Asia (WHO region)
91.0%
in 2024
Eritrea rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- Eritrea
- South-East Asia (WHO region)
How they compare
Eritrea currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Eritrea's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 10 shared years of data; in 2013 it was South-East Asia (WHO region) ahead.
Eritrea ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.2% | 40.9% | 10.3% | Eritrea |
| 2020s | 100.0% | 77.8% | 22.2% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Eritrea or South-East Asia (WHO region)?
- Eritrea, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Eritrea and South-East Asia (WHO region)?
- 9.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and South-East Asia (WHO region)?
- 10 years are reported by both, from 2013 to 2024.
- How do Eritrea and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Eritrea ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.